Cytori Therapeutics reported $4.72M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Baxter International BAX:US $ 16765M 384M
Cerus CERS:US $ 54.77M 45K
Cytori Therapeutics CYTX:US $ 4.72M 287K
Genocea Biosciences GNCA:US $ 2.95M 1.2M
Haemonetics HAE:US $ 559.44M 73.68M
Infinity Pharmaceuticals INFI:US $ 0M 0M
Merrimack Pharmaceuticals MACK:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Northwest Biotherapeutics NWBO:US 16.16M 8.99M
Starpharma Holdings Ltd SPL:AU 2.91M 2.44M
Teva Pharmaceutical TEVA:IT 20.84B 777M